Lyophilisate for concentrate for solution for infusion
- Antineoplastic agents. Monoclonal antibodies.
- Trastuzumab is a recombinant humanised IgG1 monoclonal antibody that interferes with the HER2/neu receptor. Additionally, trastuzumab is a potent mediator of antibody-dependent cell-mediated cytotoxicity (ADCC).
- T-MAB is approved to first-line treatment of patients with breast and stomach cancer.
- Monoclonal antibody against the human epidermal growth factor receptor 2 (HER2).